Letter of intent due December 10, 2021
Applications due January 14, 2022
The COBRE Center for the Study of Pain and Sensory Function is calling for pilot project proposals aimed at acquiring preliminary data for NIH R01/R15/R21/SBIR/STTR or comparable grant applications and for publication in peer-reviewed journals. Studies should utilize the COBRE Histology and Imaging Core and/or Behavior Core facilities. More information about the UNE COBRE’s goals and the research core facilities can be found at http://www.une.edu/research/cobre.
Projects may request up to $25,000 per year for a maximum of two years with an earliest start date of June 1, 2022. Continuation of funding after the first year is contingent upon success in meeting project goals and approval of COBRE External Advisory Board. Proposals will be reviewed by a study section which will make funding recommendations to the External Advisory Board. All applications will require approval by NIH prior to funding. Investigators who receive support are expected to submit a progress report prior to the end of the first year outlining progress made to date, any manuscripts published, in press, or under review, and how the data acquired will contribute to an NIH application. Faculty at the University of New England, Maine Medical Center Research Institute, and University of New Hampshire are eligible to apply.
APPLICATION DEADLINES AND INFORMATION
- December 10, 2021: Letter of intent due
- Email your letter of intent to Jennifer Malon (Jmalon@une.edu).
- Your letter should include:
- Project title, list of key personnel, and a brief description of project (this information will be used to find qualified reviewers)
- January 14, 2022: Applications due
- Submitted applications must be received by Jennifer Malon via email (Jmalon@une.edu) no later than 5:00 pm. on the 14th
- Additional application details can be found at https://www.une.edu/research/cobre/projects
Questions can be directed to Jennifer Malon, 207 602-2517, Jmalon@une.edu.
Note: Pilot project awards are contingent on successful funding of the Phase 3 COBRE